Find verified Daclatasvir API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Daclatasvir for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Daclatasvir API.
Alternate Names: Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, Dimethyl N,N'-(biphenyl-4,4'-diylbis(1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1-diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)))dicarbamate
CAS No: 1009119-64-5
PubChem CID: 25154714
Mol Formula: C40H50N8O6
Mol Weight: 738.9 g/mol
IUPAC Name: methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imid -Show More
API Description: Daclatasvir is a direct-acting antiviral agent used in combination therapy for the treatment of chronic hepatitis C virus (HCV) infection. It inhibits the HCV NS5A protein, essential for viral replication and assembly.
